Securities code: 002411 securities abbreviation: Yanan Bicon Pharmaceutical Listed Company(002411) Announcement No.: 2022-012 Yanan Bicon Pharmaceutical Listed Company(002411)
Announcement on the cancellation of illegal guarantees
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Basic information of illegal guarantee matters
Yanan Bicon Pharmaceutical Listed Company(002411) (hereinafter referred to as “the company”) received the decision on administrative supervision measures issued by Shaanxi regulatory bureau of China Securities Regulatory Commission on December 31, 2021, and the company received the letter of concern on Yanan Bicon Pharmaceutical Listed Company(002411) issued by the second Department of management of listed companies of Shenzhen Stock Exchange on January 4, 2022 (the letter of concern of the company Department [2022] No. 1). In September 2020, the company acquired Xuzhou BEIMENG Logistics Co., Ltd. (hereinafter referred to as “BEIMENG logistics”), but the company provided a total of 2.796 billion yuan of guarantee for the controlling shareholder and actual controller of the company before the acquisition, and the above guarantee is still in the guarantee period; In May 2021, Xi’an Fudi Pharmaceutical Technology Development Co., Ltd., controlled by the company, provided pledge guarantee for Shanghai Banghua International Trade Co., Ltd. with its certificate of deposit of RMB 80 million. For details, see the announcement on receiving the decision on administrative supervision measures from Shaanxi regulatory bureau of China Securities Regulatory Commission (Announcement No.: 2022-001) disclosed by the company on cninfo.com on January 1, 2022.
2、 Cancellation of illegal guarantees
The cancellation of illegal guarantees involved by listed companies is as follows:
1. The company has coordinated various companies to complete the release of the physical assets of BEIMENG logistics;
2. After the seizure of BEIMENG logistics physical assets is lifted, the physical assets of BEIMENG logistics have been transferred to the listed company, and the asset transfer has been completed;
3. The company signed the equity transfer agreement with the transferee Xinyi Chiheng Logistics Co., Ltd. (a company outside the merger scope of the company) on January 19, 2022, and transferred 100% equity of BEIMENG logistics to Xinyi Chiheng Logistics Co., Ltd. at the equity transfer price of RMB 50000. At present, the equity transfer procedures have been completed, and all matters related to the equity transfer of BEIMENG logistics have been completed. At present, the notice of approval of change registration of the company issued by Xinyi market supervision and administration has been obtained, and BEIMENG logistics is no longer included in the scope of company merger.
Up to now, the illegal guarantee matters involved in the listed company have been lifted and there is no need to bear the guarantee liability; The pledge guarantee provided by Xi’an Fudi Pharmaceutical Technology Development Co., Ltd., a wholly-owned subsidiary of the company, to Shanghai Banghua International Trade Co., Ltd. with a certificate of deposit of RMB 80 million was released on August 16, 2021.
In the future, the company will strengthen internal management, strengthen compliance awareness, standardize the company’s operation, comprehensively do a good job in the company’s internal control, and earnestly safeguard the interests of listed companies and all shareholders.
3、 Other instructions
The information disclosure media designated by the company are securities times, China Securities News, Shanghai Securities News, securities daily and http://www.cn.info.com.cn, All information of the company shall be subject to the announcement published in the above media. Please pay attention to investment risks.
It is hereby announced.
Yanan Bicon Pharmaceutical Listed Company(002411) board of directors
January 28, 2002
